Scarica l'app Stockscreener
90.92
0.85%
0.77
Dopo l'orario di chiusura:
90.92
Precedente Chiudi:
$90.15
Aprire:
$89.87
Volume 24 ore:
1.35M
Relative Volume:
0.93
Capitalizzazione di mercato:
$12.17B
Reddito:
$2.51B
Utile/perdita netta:
$185.56M
Rapporto P/E:
67.85
EPS:
1.34
Flusso di cassa netto:
$517.59M
1 W Prestazione:
+4.24%
1M Prestazione:
-2.73%
6M Prestazione:
+48.63%
1 anno Prestazione:
+8.12%
Intervallo 1D:
$88.72
$91.05
Intervallo di 1 settimana:
$87.27
$91.05
Portata 52W:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Nome
Globus Medical Inc
Settore
Industria
Telefono
610-930-1800
Indirizzo
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
90.92 | 12.07B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
112.19 | 197.00B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
372.66 | 144.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
97.58 | 126.27B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
75.72 | 113.12B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.92 | 45.83B | 6.07B | 1.06B | 799.60M | 1.8527 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Aggiornamento | Needham | Hold → Buy |
| 2026-01-27 | Iniziato | TD Cowen | Buy |
| 2025-11-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-11-07 | Aggiornamento | Truist | Hold → Buy |
| 2025-10-28 | Ripresa | Stifel | Hold |
| 2025-05-27 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-01-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-19 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-30 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-02-10 | Downgrade | Loop Capital | Buy → Hold |
| 2023-02-10 | Downgrade | Needham | Buy → Hold |
| 2023-02-10 | Downgrade | Truist | Buy → Hold |
| 2023-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-28 | Iniziato | Wells Fargo | Overweight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-29 | Iniziato | Loop Capital | Buy |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2020-12-08 | Iniziato | Citigroup | Buy |
| 2020-10-20 | Iniziato | Stifel | Hold |
| 2020-08-06 | Reiterato | Needham | Buy |
| 2020-08-06 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Iniziato | Northland Capital | Market Perform |
| 2020-07-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Reiterato | Needham | Buy |
| 2020-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-12-12 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-05-24 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Reiterato | Needham | Buy |
| 2019-02-28 | Aggiornamento | UBS | Neutral → Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-27 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Reiterato | Needham | Buy |
| 2018-04-04 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Globus Medical Inc Borsa (GMED) Ultime notizie
Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q4 Earnings - Yahoo Finance
Impingement Syndrome Market: Future Business Opportunities - openPR.com
Globus Medical to Report Fourth-Quarter and Full-Year 2025 Results February 24 - MyChesCo
Medical Robotics Market to Reach US$ 63.55 Billion by 2033 | CAGR - openPR.com
Globus Medical, Inc. (GMED) Stock Analysis: Strong Revenue Growth and 21.66% Potential Upside Attract Investors - DirectorsTalk Interviews
Is It Time To Reassess Globus Medical (GMED) After Mixed Returns And DCF Upside? - Yahoo Finance
Does Analyst Upgrades After Margin Expansion Change The Bull Case For Globus Medical (GMED)? - Yahoo Finance
Globus Medical Inc. (GMED) Gains Positive Attention Amid Improving Outlook - Finviz
How cyclical is Globus Medical Inc. Class stock compared to rivalsForecast Cut & Community Shared Stock Ideas - mfd.ru
How do insiders feel about Globus Medical Inc.July 2025 Outlook & Precise Swing Trade Entry Alerts - mfd.ru
Why Globus Medical Inc. stock is considered a top pickMarket Weekly Review & Fast Moving Stock Trade Plans - mfd.ru
How cyclical is Globus Medical Inc. (GM0N) stock compared to rivals2025 Valuation Update & Growth Oriented Trade Recommendations - mfd.ru
Is Globus Medical (GMED) Pricing Look Attractive After Recent Sideways Share Performance - Sahm
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call - marketscreener.com
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz
Versor Investments LP Invests $664,000 in Globus Medical, Inc. $GMED - MarketBeat
Madison Asset Management LLC Sells 58,971 Shares of Globus Medical, Inc. $GMED - MarketBeat
Will Globus Medical Inc. stock maintain dividend yieldWeekly Trade Review & Fast Exit and Entry Strategy Plans - mfd.ru
Globus Medical (GMED) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Globus Medical Reports Record Sales and Strong Growth in 2024 - MSN
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - Yahoo Finance
Can Globus Medical Inc. reach all time highs this year - mfd.ru
Candriam S.C.A. Sells 43,909 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (NYSE:GMED): A Prime Example of Affordable Growth - ChartMill
Globus Medical (GMED) Valuation Check After Mixed Short Term Returns And 16.6% Undervaluation View - Sahm
Thrivent Financial for Lutherans Sells 194,537 Shares of Globus Medical, Inc. $GMED - MarketBeat
Foresight Group Ltd Liability Partnership Raises Stake in Globus Medical, Inc. $GMED - MarketBeat
How Globus Medical’s Robotics and Digitization Push Will Impact Globus Medical (GMED) Investors - Sahm
New York State Common Retirement Fund Sells 77,412 Shares of Globus Medical, Inc. $GMED - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Value Stock - Yahoo Finance
Globus Medical (GMED) Valuation Check After Mixed Short Term Share Performance - Yahoo Finance
2 Reasons to Watch GMED and 1 to Stay Cautious - Yahoo Finance
Is Globus Medical (GMED) Pricing Fair After The Recent Healthcare Sector Reassessment? - Sahm
Van Berkom & Associates Inc. Purchases 48,906 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical IncA (NYSE:GMED) Shows Strong Fundamentals and Technical Setup for Growth - ChartMill
Globus Medical, Inc. (GMED): Analyst Consensus and Growth Potential Highlight an 18% Upside - DirectorsTalk Interviews
Zacks Research Lifts Earnings Estimates for Globus Medical - MarketBeat
At US$90.68, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List? - 富途牛牛
Dip Buying: Will Globus Medical Inc benefit from government policy2025 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
CEO Change: Can Origin Materials Inc outperform under higher oil prices2025 AllTime Highs & Growth Focused Entry Point Reports - baoquankhu1.vn
Assessing Globus Medical (GMED) Valuation After Investor Letter Highlights Reaccelerating Spine Growth And Integration Progress - Sahm
Needham upgrades Globus Medical stock to Buy on margin expansion By Investing.com - Investing.com Canada
Needham Upgrades Globus Medical to Buy From Hold, Sets $112 Price Target - marketscreener.com
The Analyst Verdict: Globus Medical In The Eyes Of 13 Experts - Benzinga
This Southwest Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
Analyst Upgrade: Needham Upgrades GMED to 'Buy' Rating | GMED St - GuruFocus
Globus Medical (NYSE:GMED) Upgraded by Needham & Company LLC to "Buy" Rating - MarketBeat
Needham Upgrades Globus Medical (GMED) - Nasdaq
TD Cowen Upgrades Globus Medical (NYSE:GMED) to "Strong-Buy" - MarketBeat
Cambiar Investors LLC Sells 55,919 Shares of Globus Medical, Inc. $GMED - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Momentum Stock - sharewise.com
Globus Medical Inc Azioni (GMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.02%
0.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):